| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |